HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process.
暂无分享,去创建一个
Michal Douša | Jan Doubský | Petr Gibala | J. Doubský | J. Srbek | Michal Douša | Robert Klvaňa | Jan Srbek | Jindřich Richter | Marek Exner | Robert Klvaňa | Petr Gibala | J. Richter | Marek Exner | R. Klvaňa
[1] C. Welch,et al. Evaluation of a compact mass spectrometer for routine support of pharmaceutical chemistry. , 2014, Journal of pharmaceutical and biomedical analysis.
[2] G. Gresham,et al. Identification of the nitrogen-based blister agents bis(2-chloroethyl)methylamine (HN-2) and tris(2-chloroethyl)amine (HN-3) and their hydrolysis products on soil using ion trap secondary ion mass spectrometry. , 2000, Journal of mass spectrometry : JMS.
[3] C. Sánchez,et al. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: Evidence for direct 5-HT receptor modulation , 2014, European Neuropsychopharmacology.
[4] C. Halldin,et al. 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects , 2013, European Neuropsychopharmacology.
[5] J. Buchbjerg,et al. Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant , 2013, Clinical Drug Investigation.
[6] A. Robichaud,et al. A General and Convenient Synthesis of N‐Aryl Piperazines. , 2006 .
[7] G. J. Jong,et al. A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis , 2011, Analytical and bioanalytical chemistry.
[8] T. Okui,et al. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. , 1986, Mutation research.
[9] R. Hen,et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice , 2013, Neuropharmacology.
[10] J. Wolff,et al. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API). , 2008, Journal of pharmaceutical and biomedical analysis.
[11] David Q. Liu,et al. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process. , 2009, Journal of pharmaceutical and biomedical analysis.
[12] D. Elder,et al. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.
[13] Andrew Teasdale,et al. ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .
[14] Jun Wang,et al. Ultra high performance liquid chromatography coupled with high resolution quantitation mass spectrometry method development and validation for determining genotoxic 2,5-dichlorobenzoyl chloride in MLN9708 drug substance. , 2014, Journal of pharmaceutical and biomedical analysis.
[15] David Q. Liu,et al. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. , 2008, Journal of pharmaceutical and biomedical analysis.
[16] W. Grimm. Stability Testing: Photostability Testing of New Drug Substances and Products , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.
[17] David Q. Liu,et al. Analytical challenges in stability testing for genotoxic impurities , 2013 .
[18] Christophe Croux,et al. Linearity of calibration curves: use and misuse of the correlation coefficient , 2002 .
[19] D. Brusick,et al. The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1986, Mutation research.
[20] James A. Baker,et al. Decontamination of chemical warfare agents , 1992 .
[21] N V V S S Raman,et al. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective. , 2011, Journal of pharmaceutical and biomedical analysis.
[23] R. A. Scott,et al. Use of 2-mercaptopyridine for the determination of alkylating agents in complex matrices: application to dimethyl sulfate. , 2005, Talanta.